The fibrinolytic pathway in the human fetus.
The fibrinolytic pathway and the protease inhibitors in 12 to 24-and 24-to 36-week-old fetuses were examined and compared with full-term newborns. The activity of the fibrinolytic system, as well as the values of the protease inhibitors approach the normal values progressively with the embryonic maturation.